Viewing Study NCT00026312

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:09 AM
Ignite Modification Date: 2026-01-27 @ 6:41 AM
Study NCT ID: NCT00026312
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-24
First Post: 2001-11-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Localized Resectable Neuroblastoma View
None Localized Unresectable Neuroblastoma View
None Recurrent Neuroblastoma View
None Regional Neuroblastoma View
None Stage 4 Neuroblastoma View
None Stage 4S Neuroblastoma View
Keywords: